[Significance of somatostatin receptors for diagnosis and therapy of endocrine pancreatic tumors].
Schusdziarra
V
V
II. Med. Klinik und Poliklinik, Technischen Universität, Klinikum rechts der Isar, Müchen, Bundersrepublik Deutschland.
D001345:Autoradiography; D002455:Cell Division / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007457:Iodine Radioisotopes; D009376:Neoplasms, Hormone-Dependent / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011877:Radionuclide Imaging; D017981:Receptors, Neurotransmitter / Q000032:analysis / Q000187:drug effects*; D017481:Receptors, Somatostatin
D007457:Iodine Radioisotopes; D017981:Receptors, Neurotransmitter; D017481:Receptors, Somatostatin; D015282:Octreotide
Bedeutung von Somatostatin-rezeptoren für Diagnostik und Therapie endokriner Pankreastumoren.